Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about AbbVie Inc

Recent news which mentions AbbVie Inc

< Previous 1 2 Next >
Trump's drug price ultimatum sets pharma firms scrambling
Tags Merck & Co Inc Bristol/Myers Squibb Co GSK plc
From CNBC.com News
Trump's pharmaceutical tariffs could affect some drugmakers more than others
Tags Merck & Co Inc Health care industry Bristol/Myers Squibb Co
From CNBC.com News
Trump threatens to put up to 200% tariff on pharmaceuticals 'very soon'
Tags Health care industry Biotechnology Pharmaceuticals
From CNBC.com News
Democrats press Pfizer, J&J and others over low tax bills and lobbying as Senate debates Trump's plan
Tags Biotech and Pharmaceuticals Democrats Health & Science
From CNBC.com News
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
Tags LILLY DRN Business News Merck & Co Inc
From CNBC.com News
Jim Cramer suggests why it's hard to own traditional 'safety' stocks here
Tags U/S/ Markets General Mills Inc Johnson & Johnson
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags Biotechnology Novo Nordisk A/S AstraZeneca PLC
From CNBC.com News
Trump signs order to boost domestic drug manufacturing as pharma tariff threat looms
Tags Abbvie Inc Breaking News: Business Politics
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags Mergers Roche Holding AG LILLY DRN
From CNBC.com News
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Tags LILLY DRN Abbvie Inc Merck & Co Inc
From CNBC.com News
Cramer's week ahead: Earnings from Tesla, Alphabet, Capital One and Boeing
Tags T/Mobile US Inc Stock markets Tesla Inc
From CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
Tags Companies US: News AstraZeneca PLC
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Pfizer Inc Gilead Sciences Inc Markets
From CNBC.com News
Ad spending on women's sports more than doubled last year
Tags Allstate Corp Women's sports Television
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags LILLY DRN Abbvie Inc Novo Nordisk A/S
From CNBC.com News
Cramer's Lighting Round: AbbVie is a buy
Tags Coinbase Global Inc Abbvie Inc MongoDB Inc
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Pfizer Inc Health care industry GSK plc
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags Caterpillar Inc Amgen Inc Toll Brothers Inc
From CNBC.com News
Cramer's Lightning Round: Sweetgreen is 'terrific'
Tags Stock Picks GXO Logistics Inc Market Outlook
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Eli Lilly and Co Equity Residential Stock markets
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Politics Merck & Co Inc Abbvie Inc
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Johnson & Johnson Abbvie Inc Politics
From CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
Tags Healthy Returns Teva Pharmaceutical Industries Ltd Abbvie Inc
From CNBC.com News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Tags Abbott Laboratories US: News Business
From CNBC.com News
After 8 months stuck in orbit, Varda's drug spacecraft gets FAA approval to return
Tags Business News Breaking News: Technology Breaking News: Business
From CNBC.com News
Cramer's Lightning Round: AbbVie is 'a very good company'
Tags Markets stocks S&P 500
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Tags US: News Business Amgen Inc
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
Tags Pfizer Inc Pharmaceuticals Biotechnology
From CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
Tags Stock Picks Cerevel Therapeutics Holdings Inc Seagen Inc
From CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
Tags Health care industry Bristol/Myers Squibb Co Pharmaceuticals
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.